logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

John COX Named President and CEO of Dyne Therapeutics

Mar 25, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Dyne Therapeutics

John Cox
WalthamTherapeuticsBiotechnologyHealth Care

Description

Dyne Therapeutics announces the appointment of John Cox as President, CEO, and member of the Board of Directors, effective immediately. The former CEO, Joshua Brumm, has chosen to step down to pursue a career in healthcare investing and will serve as an advisor to ensure a seamless transition.

Company Information

Company

Dyne Therapeutics

Location

Waltham, Massachusetts, United States

About

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months